Altered intestinal microbiota and blood T cell phenotype are shared by patients with Crohn's disease and their unaffected siblings

Gut

Volumn 63, Issue 10, 2014, Pages 1578-1586

  Hedin, Charlotte R ^a,b   McCarthy, Neil E ^b   Louis, Petra ^c   Farquharson, Freda M ^c   McCartney, Sara ^d   Taylor, Kirstin ^e   Prescott, Natalie J ^e   Murrells, Trevor ^e   Stagg, Andrew J ^b   Whelan, Kevin ^a   Lindsay, James O ^b,f  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c ROWETT RESEARCH INSTITUTE   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f BARTS HEALTH NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA7 INTEGRIN; CALGRANULIN; RNA 16S;

ARTICLE; BACTERIA; CD4+ T LYMPHOCYTE; CELL HOMING; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FAECALIBACTERIUM PRAUSNITZII; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTESTINE FLORA; MALE; MEMORY T LYMPHOCYTE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; ROSEBURIA; SIBLING; T LYMPHOCYTE; ADOLESCENT; ADULT; BACTERIAL PATHOGENESIS; DYSBIOSIS; FECES; GENOTYPE; IMMUNOLOGY; IMMUNOPHENOTYPING; INTESTINE MUCOSA; MICROBIOLOGY; MICROFLORA; T LYMPHOCYTES; UNITED KINGDOM; YOUNG ADULT;

BACTERIAL PATHOGENESIS; CROHN'S DISEASE; GENOTYPE; T LYMPHOCYTES;

ADOLESCENT; ADULT; CROHN DISEASE; DYSBIOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; GENOTYPE; GREAT BRITAIN; HUMANS; IMMUNOPHENOTYPING; INTESTINAL MUCOSA; MALE; MICROBIOTA; SIBLINGS; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84908507536     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2013-306226     Document Type: Article

References (43)

1. Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012;491:119-24.
2. Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 2008;105:16731-6.
3. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008;134:577-94.
4. Strober W, Fuss IJ. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology 2011;140:1756-67.
5. Hart AL, Kamm MA, Knight SC, et al. Quantitative and functional characteristics of intestinal-homing memory T cells: analysis of Crohn's disease patients and healthy controls. Clin Exp Immunol 2004;135:137-45.
6. Garcia de TJ, Manzano L, Leal JC, et al. Active Crohn's disease patients show a distinctive expansion of circulating memory CD4+CD45RO+CD28null T cells. J Clin Immunol 2004;24:185-96.
7. Tibble JA, Sigthorsson G, Bridger S, et al. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology 2000;119:15-22.
8. Buhner S, Buning C, Genschel J, et al. Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation? Gut 2006;55:342-7.
9. Meuwis MA, Vernier-Massouille G, Grimaud JC, et al. Serum calprotectin as a biomarker for Crohn's disease. J Crohns Colitis 2013;7:e678-83.
10. Calkins BM, Mendeloff AI. Epidemiology of inflammatory bowel disease. Epidemiol Rev 1986;8:60-91.
11. Hedin CR, Stagg AJ, Whelan K, et al. Family studies in Crohn's disease: new horizons in understanding disease pathogenesis, risk and prevention. Gut 2012;61:311-18.
12. Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature 2009;461:747-53.
13. Thjodleifsson B, Sigthorsson G, Cariglia N, et al. Subclinical intestinal inflammation: an inherited abnormality in Crohn's disease relatives? Gastroenterology 2003;124:1728-37.
14. Munkholm P, Langholz E, Hollander D, et al. Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first degree relatives. Gut 1994;35:68-72.
15. Soderholm JD, Olaison G, Lindberg E, et al. Different intestinal permeability patterns in relatives and spouses of patients with Crohn's disease: an inherited defect in mucosal defence? Gut 1999;44:96-100.
16. May GR, Sutherland LR, Meddings JB. Is small intestinal permeability really increased in relatives of patients with Crohn's disease? Gastroenterology 1993;104:1627-32.
17. Joossens M, Huys G, Cnockaert M, et al. Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut 2011;60:631-7.
18. Turpin W, Moreno-Hagelsieb G, Silverberg MS, et al. Specific Crohn's Disease (CD) associated risk alleles are associated with the composition of the intestinal microbiota in healthy First Degree Relatives (FDR) of CD subjects. Gastroenterology 2013;142:S57.
19. Franke A, McGovern DP, Barrett JC, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 2010;42:1118-25.
20. Kraus TA, Cheifetz A, Toy L, et al. Evidence for a genetic defect in oral tolerance induction in inflammatory bowel disease. Inflamm Bowel Dis 2006;12:82-8.
21. Joshi S, Lewis SJ, Creanor S, et al. Age-related faecal calprotectin, lactoferrin and tumour M2-PK concentrations in healthy volunteers. Ann Clin Biochem 2010;47:259-63.
22. Woodmansey EJ, McMurdo ME, Macfarlane GT, et al. Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotic-treated and non-antibiotic-treated elderly subjects. Appl Environ Microbiol 2004;70:6113-22.
23. Ramirez-Farias C, Slezak K, Fuller Z, et al. Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br J Nutr 2009;101:541-50.
24. Dabek M, McCrae SI, Stevens VJ, et al. Distribution of beta-glucosidase and beta-glucuronidase activity and of beta-glucuronidase gene gus in human colonic bacteria. FEMS Microbiol Ecol 2008;66:487-95.
25. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
26. Cortes A, Brown MA. Promise and pitfalls of the Immunochip. Arthritis Res Ther 2011;13:101.
27. Crouch DJ, Goddard GH, Lewis CM. REGENT: a risk assessment and classification algorithm for genetic and environmental factors. Eur J Hum Genet 2013;21:109-11.
28. Goddard GH, Lewis CM. Risk categorization for complex disorders according to genotype relative risk and precision in parameter estimates. Genet Epidemiol 2010;34:624-32.
29. Mahmood A, Fitzgerald AJ, Marchbank T, et al. Zinc carnosine, a health food supplement that stabilises small bowel integrity and stimulates gut repair processes. Gut 2007;56:168-75.
30. Selby WS, Jewell DP. T lymphocyte subsets in inflammatory bowel disease: peripheral blood. Gut 1983;24:99-105.
31. Mathew CG, Lewis CM. Genetics of inflammatory bowel disease: progress and prospects. Hum Mol Genet 2004;13 Spec No 1:R161-8.
32. Flint HJ, Scott KP, Louis P, et al. The role of the gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol 2012;9:577-89.
33. Smith PM, Howitt MR, Panikov N, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013;341:569-73.
34. Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core gut microbiome in obese and lean twins. Nature 2009;457:480-4.
35. Willing B, Dicksved J, Halfvarson J, et al. A pyrosequencing study in twins shows that GI microbial pro files vary with inflammatory bowel disease phenotypes. Gastroenterology 2010;139:1844-54.
36. Spor A, Koren O, Ley R. Unravelling the effects of the environment and host genotype on the gut microbiome. Nat Rev Microbiol 2011;9:279-90.
37. Malmborg P, Bahmanyar S, Grahnquist L, et al. Cesarean section and the risk of pediatric Crohn's disease. Inflamm Bowel Dis 2012;18:703-8.
38. Kieper WC, Troy A, Burghardt JT, et al. Recent immune status determines the source of antigens that drive homeostatic T cell expansion. J Immunol 2005;174:3158-63.
39. Bargatze RF, Jutila MA, Butcher EC. Distinct roles of L-selectin and integrins alpha 4 beta 7 and LFA-1 in lymphocyte homing to Peyer's patch-HEV in situ: the multistep model confirmed and refined. Immunity 1995;3:99-108.
40. Wagner N, Lohler J, Kunkel EJ, et al. Critical role for beta7 integrins in formation of the gut-associated lymphoid tissue. Nature 1996;382:366-70.
41. Cimbro R, Vassena L, Arthos J, et al. Interleukin-7 induces expression and activation of integrin alpha4beta7 promoting naive T-cell homing to the intestinal mucosa. Blood 2012;120:2610-19.
42. Halfvarson J. Genetics in twins with Crohn's disease: less pronounced than previously believed? Inflamm Bowel Dis 2011;17:6-12.
43. Tysk C, Lindberg E, Jarnerot G, et al. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 1988;29:990-6.